In vitro Antibacterial Activity of Chinfloxacin, a New Fluoroquinolone Antibiotic
Guoqing Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Xuefu You(Chinese Academy of Medical Sciences & Peking Union Medical College), Jian‐Dong Jiang(Ningbo University), Xuan-Wang You(Zhangqiu City People's Hospital), Xinyi Yang(University of Sussex), Ruite Lou(Chinese Academy of Medical Sciences & Peking Union Medical College), Shan Cen(Chinese Academy of Medical Sciences & Peking Union Medical College), Weixin Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Huiyuan Guo(Chinese Center For Disease Control and Prevention), Congran Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Xinxin Hu(Chinese Academy of Medical Sciences & Peking Union Medical College), Min Yuan(National Institute for Communicable Disease Control and Prevention)
Cited by 2
Related Papers
Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents
|Gut|2020|578
ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent
|Cancer Cell|2005|368
SCFAs alleviated steatosis and inflammation in mice with NASH induced by MCD
|Journal of Endocrinology|2020|203